Interaction of PUFAs and Doxorubicin: the Enhanced Toxicity in Breast Cancer Cells
Doxorubicin (DOX) still remains one the most effective a clinical drug for breast cancer treatment. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the n-3 polyunsaturated fatty acids (PUFAs), exert pronounced toxicity against many types of cancers including breast cancer. That is why it...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Polskie Towarzystwo Farmaceutyczne,
2023-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|